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The development of B cells is accompanied by their ability to specifically enter the peripheral
lymphoid tissues. Recently, we described a novel rat monoclonal antibody (IBL-2; IgG2b/t0
reacting with a 26/29-kD heterodimeric structure of the cell surface. This mAb has been found
to recognize differentially the peripheral B cells of mice depending on their tissue origin. The
majority of splenic B cells as well as the mature B cells in the bone marrow were stained with
this mAb, whereas the B lymphocytes isolated from LN or Peyer’s patches displayed only
negligible reactivity. We extended these observations by analyzing the relationship between the
expression of IBL-2 antigen and L-selection on the surface of B-cell precursors in the bone
marrow by multiparameter flow cytometry. Within the B220 positive compartment, a significant
difference of L-selectin expression could be observed between the various IBL-2-reactive
subsets. Furthermore, we investigated whether evidences for the establishment of tissue-
associated phenotypic heterogeneity similar to that found in normal mice could be found upon
the adoptive transfer of normal unselected splenic lymphocytes into SCID recipients (Spl-SCID).
It has been found that a large part of the splenic B cells preserved their IBL-2 reactivity, whereas
the LN B cells had lost the IBL-2 antigen in Spl-SCID. These data indicate that the phenotypic
difference within the SCID mice may be the result of the migration of B lymphocytes from the
spleen toward the lymph nodes, and the altered expression of the IBL-2 antigen correlates with
this process.
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INTRODUCTION
The spleen is a major target organ for peripheral
lymphocyte homing. Its histological architecture is
rather complex, partly composed of erythromyeloid
regions containing some migrating lymphoid ele-
Corresponding author.
ments. This red pulp is intermingled with lymphoid
white pulp that, according to its cellular content, is
further subdivided into T- and B-cell compartments
(van Ewijk and Nieuwenhuis, 1985). This consider-
able cellular and functional heterogeneity has signifi-
cantly hampered the understanding of how the
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lymphocytes may localize to specific regions.
Whereas the splenic recirculation kinetics of both the
T and B cells have been thoroughly studied (Stevens
et al., 1982; Pabst and Westermann, 1991; Picker and
Butcher, 1992), little is known about the cellular
interactions leading to their extravasation and sub-
sequent tissue positioning. The sinus-lining cells and,
less likely, the marginal zone macrophages in the
spleen have been reported to perform binding func-
tions similar to those of HEV cells (Kraal et al., 1995;
Lyons and Parish, 1995). However, the adhesion of of
lymphocytes to either of these cells in the spleen
appears to be independent of the L-selectin or c4/37
molecules, the characteristic leukocyte structures for
binding to HEV in the lymph nodes and mucosal
lymphoid tissues, respectively (Picker and Butcher,
1992; Bradley et al., 1994). It is worthwhile to
mention that the splenic but not the bone marrow
homing of myeloid precursors has proved to be
independent of the interactions between the VCAM-1
and VLA-4 molecules (Papayannopoulou et al.,
1995).
The details of the in situ migration of lymphocytes
subsequent to the extravasation are also largely
unknown. It is supposed that various polysaccharides
produced by microenvironmental elements may con-
tribute to the lymphoid organization of the spleen
(Parish and Snowden, 1985; Kraal et al., 1994). On
the other hand, it is not only the microenvironment
that influences the lymphocyte migration, but the
presence of certain lymphoid elements can also
modulate the composition of the mesenchymal scaf-
folding, according to the results obtained in SCID
mice (Yoshida et al., 1993). Under normal circum-
stances, the splenic entry of lymphocytes can be
divided into two subsequent parts. The extravasation
into the red pulp is independent from G-protein-
coupled lymphocyte membrane components inhibited
by pertussis toxin (PTX), whereas the subsequent
migration of T and B lymphocytes from the red pulp
toward the various compartments of white pulp is
likely to be mediated by PTX-sensitive structures
(Cyster and Goodnow, 1995). It is also not known
whether what kind of phenotypic alterations take
place in the lymphocytes upon their splenic lodging or
return from the spleen to the circulation.
We have recently reported the isolation and
characterization of a novel rat monoclonal antibody
IBL-2. This mAb reacts with the mature B cells
(identified as lg-positive cells) purified from spleen or
bone marrow, whereas the B cells from other
peripheral lymphoid tissues were not recognized. The
T cells, including the splenic T cells, do not express
the antigen (Balogh et al., 1992; Balogh and Kumfi-
novics, 1995). Here we extend these observations by
investigating the coexpression of L-selectin and IBL-
2 antigens on B-cell precursors in the bone marrow. In
addition, we report the result of experiments employ-
ing adoptive cell transfer of normal BALB/c splenic
lymphocytes into SCID recipients. These experiments
were aimed at confirming the differential reactivity of
peripheral B cells with IBL-2 mAb determined by
their tissue location.
RESULTS AND DISCUSSION
Coexpression of IBL-2 Antigen and L-Selectin on
B-Cell Precursors in Bone Marrow
Our previous finding was that, employing anti-
immunoglobulin antibodies as lineage marker, the
reactivity pattern of splenic B cells was quite similar
to that of marrow B cells. The majority of these cells
of either source also expressed L-selectin (Balogh et
al., 1995). In order to determine the simultaneous
expression of L-selectin and IBL-2 antigen on
immature B-cell precursors, we first depleted the bone
marrow cells of cell-bearing Ig on their surface. The
residual cells were labeled with an anti-B220 (RA3-
6B2), MEL-14, and IBL-2 mAbs. A representative
example of these three-color stainings are shown in
Figure 1.
The majority of the B220 cells are IBL-2-negative
(approximately 58%), whereas the rest are either
weakly or strongly reactive with this mAb (approxi-
mately 32% and 10%, respectively). This is in
contrast with our previous finding that the Ig-positive
bone marrow cell subset contained considerably
higher frequency of IBL-2 cells, ranging between
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the 60-70% of total (mature) B cells (Balogh et al.,
1995) The B220- population could be resolved into
two strikingly different subsets: one is IBL-2-neg-
ative, whereas the other one was found to react with
this antibody very intensely (IBL-2hi). Slightly more
than 50% of the latter cells also expressed the L-
selectin (bottom right panel) at a detectable level. As
the B-cell precursors express the B220 antigen rather
early in their development, however, it is likely that
the majority of B220- population is composed of
non-B lineage cells.
Although the expression patterns of L-selectin by
B220+/IBL-2 and B220+/IBL-2 populations do not
differ from each other significantly (top middle and
right panels), there is an almost threefold increase of
the MEL-14 positive subset within the B220+/IBL-2hi
compartment (bottom middle panel). The question
may arise whether the L-selectin molecule is func-
tional on these B220+/IBL-2l or B220+/IBL-2hi cells.
It has been demonstrated that even though the
granulocytic cells may become MEL-14 positive
upon the in vitro culture of their L-selectin negative
precursors induced by a variety of soluble factors,
they are unable to bind to HEV cells, presumably due
to the lack of other adhesion molecules (Salmi and
Jalkanen, 1992).
To our knowledge, there are no data concerning the
L-selectin expression during the various stages of
murine B-cell differentiation in the bone marrow.
Therefore, we can only extrapolate from data obtained
in humans, indicating that the expression of CD62L is
restricted to the the later phase of medullary B-cell
differentiation (Kansas and Dailey, 1989).
IBL-2 Phenotype of Peripheral B Cells in SCID
Transplanted with Normal Spleen Cells
Our previous finding indicated the location-dependent
reactivity of the IBL-2 mAb on B cells from various
peripheral lymphoid organs of normal lymphopoietic
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FIGURE Relationship between the expression of L-selectin and IBL-2 antigen on B-cell precursors in the bone marrow. Adult bone
marrow cells depleted of IgM-positive cells were stained with anti-B220 and IBL-2 and MEL-14 mAbs labeled with different fluorochromes
as described in Materials and Methods. The various regions (3-6) shown on the contour plot (gated on lymphocytes) were used to analyze
the expression of L-selectin by the different subsets (histograms). The numbers at the regions indicate the percentage of positive cells
obtained by an irrelevant control rat IgG.
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mice. In our subsequent studies, we used SCID mice
as recipients to study the possible phenotypic altera-
tions affecting the IBL-2 antigen expression of B cells
upon their migration from the spleen to the lymph
nodes. BALB/c-derived splenic cells as IBL-2-posi-
tive cell source was employed. Three days after the
intravenous administration of lymphocytes, different
lymphoid organs of the recipients were assayed for
the IBL-2 profile of B cells (identified as IgM-positive
cells). We found this time point as the earliest to allow
lymphocytes to be obtained from lymph nodes (LN)
in sufficent amount for flow cytometry.
By the end of this period, the overwhelming
majority of B cells recovered from the recipients LNs
had become IBL-2-negative, even though the original
spleen-cell suspension contained a significant amount
of IBL-2l B cells. On the other hand, a significant
proportion of B cells of the hosts spleens still retained
the IBL-2 antigen on their surface. It is noteworthy
that, compared to BALB/c control spleens, the IBL-
2-negative B-cell subset slightly increased, and the
size of the IBL-2hi compartment was also reduced
(Table I). The reasons for these discrepancies are
unclear. Our hypothesis is that it probably reflects the
difference in the lymphopoietic homeostasis of the
spleen between the normal mice and Spl-SCID. In
normal mice, the splenic influx of B cells is
maintained from both the de novo formed B cells
released from the bone marrow that are relatively
immature (Allman et al., 1993) and fully mature B
cells returning from other peripheral lymphoid
organs. In Spl-SCID mice, the former source is
negligible, whereas a considerable portion of B cells
inoculated may have recirculated several times during
the 3-day period, taking into account the relatively
fast speed of splenic homing (Brelinska et al., 1984;
Willfuhr et al., 1989). The T cell remained IBL-
2-negative.
The dual staining of splenocytes with an anti-CD45
and IBL-2 mAbs revealed three main populations:
CD45+/IBL-2-, CD45+/IBL-21, and CD451/IBL-2hi.
A small, but consistently detectable subset expressed
the CD45+/IBL-2hi phenotype (not shown). Of these,
the CD45/IBL-2hi subset may represent some extra-
medullary erythroid-committed progenitors (manu-
script in preparation). The origin of IBL-22hi non-B
cells (donor/recipient) in the transplanted animals was
not further investigated.
The control SCID mice did not contain detectable
number of B cells, even though some Thy-l-positive
cells could be observed. Another finding was that they
also almost completely lack the IBL-2l population,
whereas the IBL-2hi subset is clearly present, approxi-
mately at the same frequency as in normal BALB/c
mice (not shown).
The tissue distribution of the IBL-2-reactive ele-
ments in the spleen appeared to be similar in both the
transplanted and control SCID mice (Figure 2). The
strongly positive cells tend to form a ring around the
white pulp, where the cells are arranged in tight
clusters containing around 20 to 70 cells. The
similarity of immunohistochemical staining of the
spleen of the control and injected SCID mice with
IBL-2 mAb together with FACS data indicate that the
majority of these bright cells are of non-B lineage.
However, at the interpretation of the negative immu-
nohistochemical staining of a B-cell area, one must
take into account that, according to our quantitative
FACS data, the level of IBL-2 antigen expression on
TABLE Distribution of IBL-2-Reactive B Cells in SCID Mice
Cell sample analyzed IBL-2-negative IBL-2 IBL-2
BALB/c spleen 34.7 4.2 47.1 3.2 17.9 +_ 3.7
BALB/c lymph node 94.4 3.4 2.7 _+ 0.7 2.1 0.6
Spl-SCID spleen 57.3 4.2 38.3 4.7 4.7 1.3
Spl-SCID lymph node 91.7 6.4 3.4 1.4 1.9 0.8
Note: The results of spleen are the average SD of five mice analyzed individually; the lymph node results are the average SD of pooled
lymph node suspensions from four mice. The B cells were identified using biotinylated anti-IgM antibodies.
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supernatant. After 1-hr incubation at room tempera-
ture, the specimens were washed and further incu-
bated in the dark with FITC-conjugated affinity-
purified sheep anti-rat IgG antibodies. After washing,
the specimens were mounted with PBS-glycerol and
viewed under a Nikon FXA epifluorescent micro-
scope.
fixed in 1% buffered paraformaldehyde. The samples
were run on a Becton-Dickinson FACSCalibur flow
cytometer and analyzed with the CellQuest software
package.
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Depletion of B Cells from the Bone Marrow
The bone marrow cells were depleted of mature B
cells by using rosette technique. Briefly, the bone
marrow cells were incubated with rat anti-mouse IgM
mAb (Serotec, UK) followed by washing. The cells
were further incubated with sheep erythrocytes
(SRBC) precoated with affinity-purified sheep anti-rat
IgG. The mixture was incubated at 4C, with constant
rotation in PBS contatinig 0.1% BSA and Na-azide.
The rosetted cells were rerosetted by adding SRBC
precoated with rat IgG (Hunt, 1986).
Flow Cytometric Analyses
The flow cytometric analyses were performed on cell
suspensions from various lymphocyte sources using a
cocktail of monoclon’al antibodies. For two-color
staining, the cells were incubated with IBL-2 super-
natant, followed by FITC-conjugated anti-rat IgG.
The residual binding sites of the secondary antibodies
were blocked by normal rat serum. After washing,
biotinylated rat mAbs (anti-mouse Thy-1, anti-mouse
IgM [LO-MM-9, Serotec] anti-mouse CD45) were
added, that were subsequently detected with PE-
streptavidin (Sigma).
The expression of IBL-2 antigen correlated with
that of L-selectin on B cells and on their precursors in
the bone marrow was detected using a three-color
staining procedure. Normal bone marrow or spleen
cells were incubated with PE-labeled anti-mouse
CD45RA mAb as a lineage marker and biotinylated
IBL-2 mAb, which was revealed using CyChrome-
streptavidin (PharMingen, USA). The appearance of
L-selectin on the B220-positive compartment was
determined by their subsequent staining with FITC-
labeled MEL-14 mAb. After staining, the cells were
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